A multicenter study on the use of interferon gamma in CGD patients demonstrated 77% reduction in serious infections compared to the placebo group: the effect was more pronounced in the younger age group when combined with antimicrobial prophylaxis (32). The gene discussed is IFNG; the disease is chronic granulomatous disease.